Mobile App

Google Play Apple Store
Podcast from EASL Congress 2024: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis
AMA/ABS/ANCC/ACPE - Podcast Series

Several new developments in primary biliary cholangitis (PBC) on available and emerging therapies will be presented at the annual European Association for the Study of the Liver (EASL) 2024 Congress in Milan, Italy. In this podcast series, Dr. Kris Kowdley will discuss the most important breakthroughs in the understanding and treatment of PBC presented at the EASL Congress 2024 and will provide guidance on their impact.

Review the videos to claim AMA/ABS/ANCC/ACPE credit after completion of the brief Post-Test/Evaluation(s).



 
Kris V. Kowdley, MD, AGAF, FAASLD, FACG, FACP  Kris V. Kowdley, MD, AGAF, FAASLD, FACG, FACP
Director, Liver Institute Northwest
Professor, Elson S. Floyd College of Medicine
Washington State University

*This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings of the European Association for the Study of the Liver (EASL) Congress 2024.
20
Supported by independent educational grants from Gilead Sciences, Inc. and Intercept Pharmaceuticals, Inc.

Launch Date: June 11, 2024
Release Date: June 11, 2024
Expiration Date: May 31, 2025

Mini Module
7749
CC_EASL_PBC_Podcast(1730x162).png
Liver Disease

CookieConsent

Change Settings